BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21497592)

  • 1. Selective dihydropyiridine compounds facilitate the clearance of β-amyloid across the blood-brain barrier.
    Bachmeier C; Beaulieu-Abdelahad D; Mullan M; Paris D
    Eur J Pharmacol; 2011 Jun; 659(2-3):124-9. PubMed ID: 21497592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LRP1 mediates bidirectional transcytosis of amyloid-β across the blood-brain barrier.
    Pflanzner T; Janko MC; André-Dohmen B; Reuss S; Weggen S; Roebroek AJ; Kuhlmann CR; Pietrzik CU
    Neurobiol Aging; 2011 Dec; 32(12):2323.e1-11. PubMed ID: 20630619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective antihypertensive dihydropyridines lower Aβ accumulation by targeting both the production and the clearance of Aβ across the blood-brain barrier.
    Paris D; Bachmeier C; Patel N; Quadros A; Volmar CH; Laporte V; Ganey J; Beaulieu-Abdelahad D; Ait-Ghezala G; Crawford F; Mullan MJ
    Mol Med; 2011; 17(3-4):149-62. PubMed ID: 21170472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the cannabinoid system in the transit of beta-amyloid across the blood-brain barrier.
    Bachmeier C; Beaulieu-Abdelahad D; Mullan M; Paris D
    Mol Cell Neurosci; 2013 Sep; 56():255-62. PubMed ID: 23831388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multifaceted role for apoE in the clearance of beta-amyloid across the blood-brain barrier.
    Bachmeier C; Paris D; Beaulieu-Abdelahad D; Mouzon B; Mullan M; Crawford F
    Neurodegener Dis; 2013; 11(1):13-21. PubMed ID: 22572854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epitope-dependent effects of Beta-amyloid antibodies on Beta-amyloid clearance in an in vitro model of the blood-brain barrier.
    Bachmeier CJ; Beaulieu-Abdelahad D; Mullan MJ; Paris D
    Microcirculation; 2011 Jul; 18(5):373-9. PubMed ID: 21418385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased efflux of amyloid-β peptides through the blood-brain barrier by muscarinic acetylcholine receptor inhibition reduces pathological phenotypes in mouse models of brain amyloidosis.
    Paganetti P; Antoniello K; Devraj K; Toni N; Kieran D; Madani R; Pihlgren M; Adolfsson O; Froestl W; Schrattenholz A; Liebner S; Havas D; Windisch M; Cirrito JR; Pfeifer A; Muhs A
    J Alzheimers Dis; 2014; 38(4):767-86. PubMed ID: 24072071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apical-to-basolateral transport of amyloid-β peptides through blood-brain barrier cells is mediated by the receptor for advanced glycation end-products and is restricted by P-glycoprotein.
    Candela P; Gosselet F; Saint-Pol J; Sevin E; Boucau MC; Boulanger E; Cecchelli R; Fenart L
    J Alzheimers Dis; 2010; 22(3):849-59. PubMed ID: 20858979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Copper complexing decreases the ability of amyloid beta peptide to cross the BBB and enter brain parenchyma.
    Mare S; Penugonda S; Robinson SM; Dohgu S; Banks WA; Ercal N
    Peptides; 2007 Jul; 28(7):1424-32. PubMed ID: 17580097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum-derived immunoglobulins neutralize adverse effects of amyloid-beta peptide on the integrity of a blood-brain barrier in vitro model.
    Poetsch V; Neuhaus W; Noe CR
    J Alzheimers Dis; 2010; 21(1):303-14. PubMed ID: 20421696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgG-assisted age-dependent clearance of Alzheimer's amyloid beta peptide by the blood-brain barrier neonatal Fc receptor.
    Deane R; Sagare A; Hamm K; Parisi M; LaRue B; Guo H; Wu Z; Holtzman DM; Zlokovic BV
    J Neurosci; 2005 Dec; 25(50):11495-503. PubMed ID: 16354907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms.
    Deane R; Wu Z; Sagare A; Davis J; Du Yan S; Hamm K; Xu F; Parisi M; LaRue B; Hu HW; Spijkers P; Guo H; Song X; Lenting PJ; Van Nostrand WE; Zlokovic BV
    Neuron; 2004 Aug; 43(3):333-44. PubMed ID: 15294142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Method for measurement of the blood-brain barrier permeability in the perfused mouse brain: application to amyloid-beta peptide in wild type and Alzheimer's Tg2576 mice.
    LaRue B; Hogg E; Sagare A; Jovanovic S; Maness L; Maurer C; Deane R; Zlokovic BV
    J Neurosci Methods; 2004 Sep; 138(1-2):233-42. PubMed ID: 15325132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid clearance as a treatment target against Alzheimer's disease.
    Kurz A; Perneczky R
    J Alzheimers Dis; 2011; 24 Suppl 2():61-73. PubMed ID: 21422524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of the retinoid X receptor facilitates beta-amyloid clearance across the blood-brain barrier.
    Bachmeier C; Beaulieu-Abdelahad D; Crawford F; Mullan M; Paris D
    J Mol Neurosci; 2013 Feb; 49(2):270-6. PubMed ID: 22890420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum-derived immunoglobulins alter amyloid beta transport across a blood-brain barrier in vitro model.
    Poetsch V; Bennani-Baiti B; Neuhaus W; Muchitsch EM; Noe CR
    Pharmazie; 2010 Apr; 65(4):267-73. PubMed ID: 20432623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of LRP1 [correction of LPR1] at the blood-brain barrier in streptozotocin-induced diabetic mice.
    Hong H; Liu LP; Liao JM; Wang TS; Ye FY; Wu J; Wang YY; Wang Y; Li YQ; Long Y; Xia YZ
    Neuropharmacology; 2009; 56(6-7):1054-9. PubMed ID: 19285094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in amyloid-β clearance across mouse and human blood-brain barrier models: kinetic analysis and mechanistic modeling.
    Qosa H; Abuasal BS; Romero IA; Weksler B; Couraud PO; Keller JN; Kaddoumi A
    Neuropharmacology; 2014 Apr; 79():668-78. PubMed ID: 24467845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection of the blood-brain barrier by pentosan against amyloid-β-induced toxicity.
    Deli MA; Veszelka S; Csiszár B; Tóth A; Kittel A; Csete M; Sipos A; Szalai A; Fülöp L; Penke B; Abrahám CS; Niwa M
    J Alzheimers Dis; 2010; 22(3):777-94. PubMed ID: 20847411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial LRP1 transports amyloid-β(1-42) across the blood-brain barrier.
    Storck SE; Meister S; Nahrath J; Meißner JN; Schubert N; Di Spiezio A; Baches S; Vandenbroucke RE; Bouter Y; Prikulis I; Korth C; Weggen S; Heimann A; Schwaninger M; Bayer TA; Pietrzik CU
    J Clin Invest; 2016 Jan; 126(1):123-36. PubMed ID: 26619118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.